Form 4 for RGEN REPLIGEN CORP
Accepted 2021-11-04 00:00:00 ET · period of report 2021-11-02 · accession 0000899243-21-043040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-04 | 2021-11-02+ | RGEN | RYAN THOMAS F JR | Dir | S - Sale+OE | $295.87 | +285 | 13.3K | +2% | +$84.3K |
| D | 2021-11-04 | 2021-11-02 | RGEN | RYAN THOMAS F JR | Dir | M - OptEx | $128.18 | +1,285 | 14.6K | +10% | +$164.7K |
| D | 2021-11-04 | 2021-11-02 | RGEN | RYAN THOMAS F JR | Dir | M - OptEx | $0.00 | +1,285 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-04 | S | D | 1,000 | $288.00 | 12,337 | D | — | — | |
| 2 | Common | Common Stock | 2021-11-02 | S | A | 1,285 | $302.00 | 13,337 | D | — | — | (F2) $302.00 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $301.85 to $302.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2021-11-02 | M | A | 1,285 | $128.18 | 14,622 | D | — | — | (F1) Includes three stock option exercises totaling 12,366 shares which were not previously included in the holder's beneficial ownership totals. |
| 4 | Derivative | Stock Option (Right to Buy) | 2021-11-02 | M | A | 1,285 | $0.00 | 0 | D | $128.18 · — to 2030-05-13 | 1,285 Common Stock | (F3) This option is currently exercisable |